1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Molecular Biology Enzymes, Kits, and Reagents Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Molecular Biology Enzymes, Kits, and Reagents Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Molecular Biology Enzymes, Kits, and Reagents Market Regional Analysis
6.2 Europe Molecular Biology Enzymes, Kits, and Reagents Market Revenue 2019-2028 (US$ Million)
6.3 Europe Molecular Biology Enzymes, Kits, and Reagents Market Forecast Analysis
7. Europe Molecular Biology Enzymes, Kits, and Reagents Market Analysis – by Product
7.1 Enzymes
- 7.1.1 Overview
- 7.1.2 Enzymes: Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Kits & Reagents
- 7.2.1 Overview
- 7.2.2 Kits & Reagents: Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Molecular Biology Enzymes, Kits, and Reagents Market Analysis – by Application
8.1 Epigenetics
- 8.1.1 Overview
- 8.1.2 Epigenetics: Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Sequencing
- 8.2.1 Overview
- 8.2.2 Sequencing: Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Synthetic Biology
- 8.3.1 Overview
- 8.3.2 Synthetic Biology: Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Polymerase Chain Reaction
- 8.4.1 Overview
- 8.4.2 Polymerase Chain Reaction: Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Molecular Biology Enzymes, Kits, and Reagents Market Analysis – by End User
9.1 Biotechnological & Pharmaceutical Companies
- 9.1.1 Overview
- 9.1.2 Biotechnological & Pharmaceutical Companies: Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Hospitals & Diagnostic Centers
- 9.2.1 Overview
- 9.2.2 Hospitals & Diagnostic Centers: Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Academic & Research Institutes
- 9.3.1 Overview
- 9.3.2 Academic & Research Institutes : Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Molecular Biology Enzymes, Kits, and Reagents Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Product
- 10.2.1.1.2 UK: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by End User
- 10.2.1.2 Germany:
Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Product
- 10.2.1.2.2 Germany: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by End User
- 10.2.1.3 France:
Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Product
- 10.2.1.3.2 France: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by End User
- 10.2.1.4 Russia:
Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Product
- 10.2.1.4.2 Russia: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by End User
- 10.2.1.5 Italy:
Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Product
- 10.2.1.5.2 Italy: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by End User
- 10.2.1.6 Rest of Europe:
Europe Molecular Biology Enzymes, Kits, and Reagents Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Product
- 10.2.1.6.2 Rest of Europe: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Molecular Biology Enzymes, Kits, and Reagents Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Agilent Technologies, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Illumina, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Merck KGAA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 MERIDIAN BIOSCIENCE, INC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Promega Corporation
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Qiagen
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Rockland Immunochemicals Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 THERMO FISHER SCIENTIFIC INC
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations